ArticleACS synthetic biology2026
Machine-Learning-Assisted Pathway Optimization in Large Combinatorial Design Spaces: A p-Coumaric Acid Case Study.
Article in ACS synthetic biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparing metabolic engineering scenarios using simulated design-build-test-learn-cycles.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Combinatorial pathway optimization is a powerful approach in metabolic engineering to improve strain performance. While machine learning (ML) has shown promise in guiding the Design-Build-Test-Learn (DBTL) cycle, most applications have been limited to small design spaces, thereby restricting the potential of predictive and exploration-exploitation strategies. In this work, we applied two DBTL cycles to optimize p-coumaric acid production in Saccharomyces cerevisiae. The first cycle involved constructing a large combinatorial library of 18 genes and 20 promoters (170 million possible designs). In the second cycle, we employed a gradient bandit-based machine learning recommendation strategy, tuned to balance exploration and exploitation. Our results show that this balanced strategy outperforms greedy, feature importance-based approaches, leading to greater diversity in strain performance and improved top-producer identification. Notably, applying the same strategy to an alternative parent strain yielded the highest p-coumaric acid titer (1.23 g/L), a 2.37-fold improvement over the original. These findings highlight the value of ML-guided exploration in large design spaces and demonstrate that balancing exploration and exploitation is critical for successful strain optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.